comparemela.com

Latest Breaking News On - Lal pathlabs ltd - Page 3 : comparemela.com

Eris Lifesciences, Dr Lal Pathlabs among 8 overbought stocks with bearish RSI

Analyzing the trend of RSI provides insights into the strength and direction of stock prices. A bearish or declining RSI trend in the overbought zone indicates potential weakening momentum and a higher probability of a price reversal. It suggests that the stock s price may undergo a correction or enter a consolidation phase, providing cautionary signals to investors

Dr Lal PathLabs stock under pressure after March quarter earnings fails to impress

Dr Lal PathLabs Ltd reported 8.2 percent year on year decline in net profit for the March quarter to Rs 57 crore from Rs 62 crore. Revenue rose just 1.1 percent to Rs 491 crore from a year ago.

India Digital Healthcare Markets Report, 2022-2023 & 2027: A Consistent Rise in FDI in the Healthcare Sector has Led to a Global Focus on Investments, Product Innovation, Medical Tourism

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.